AlphAIAlphAI — Financial news for AI agents
nbr.co.nzAUG 243 min read$FPH

NZX 50 falls as investors want more from Chorus; Infratil dips

New Zealand's S&P/NZX 50 index fell 0.7% as Chorus declined 5.3% after its earnings outlook missed expectations, while Fisher & Paykel Healthcare rose 1.6% following upgraded price targets. Infratil dropped 2.1%, and SkyCity Entertainment Group surged 9.9% on potential takeover interest. Asian markets also declined, led by Alibaba's 9.8% drop.

Original reporting
nbr.co.nz
Published Aug 24, 2026, 6:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 24, 2026, 7:10 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
NZX 50 falls as investors want more from Chorus; Infratil dips — source image
Source · nbr.co.nz
Decision brief

The 30-second read

$FPHBullishMed
01

Why it matters

Sector‑specific earnings and guidance releases drove divergent moves among NZX constituents.

02

Market read

Mixed earnings and guidance outcomes created a split performance across NZX stocks, with the index down 0.7%.

03

What to watch

Potential spill‑over from Alibaba AI funding concerns could weigh on broader tech‑related stocks.

Relevance 6/10Novelty 6/10Timing: intraday today

Background

The NZX 50 fell amid a broad Asian sell‑off, with Alibaba's AI funding raise prompting risk aversion.

Company-level read

Ticker impact

$FPHBullishMedium confidence
Context

Fisher & Paykel Healthcare saw its price target raised to $46.90‑$51 and its stock rose 1.6% after upgraded guidance.

Expected impact

moderate upside in the near term

Evidence & confidence

Analyst upgrades and price target lift often precede further price gains.

Market effects

Sector

Data‑centre and infrastructure stocks face pressure, while healthcare and infrastructure services see upside.

Regional

NZ market underperformed Asia, driven by local earnings and sector news.

Global

Limited; primarily affects New Zealand‑listed equities.

Counterpoint

What could challenge this read

Despite Chorus' soft outlook, its stable earnings and dividend may attract value buyers.

Key entities

  • company
    Chorus Limited

    Broadband network operator

  • company
    Fisher & Paykel Healthcare

    Medical device maker

  • company
    Infratil

    Data‑centre investor

  • company
    SkyCity Entertainment Group

    Casino operator

  • company
    Ventia Services

    Infrastructure maintenance firm

Read at source← All news

Related articles

OCT 22
$FPHMed

Five Point Q3 Earnings Call Highlights

Five Point (FPH) expects small Q4 net income and $20M for 2026, adjusting land sale expectations. Q3 saw 54 homes sold at Great Park, 92 at Valencia. Cash position: $358.7M, liquidity: $576.2M. CFO Tobler forecasts >$300M cash by 2026, with $125M development spending planned. Management revenue: $13.9M, Hearthstone AUM: $3.4B. Progress reported at Valencia and Candlestick.

finance.yahoo.com2 min
OCT 22
$FPHMed

Five Point Holdings, LLC Reports Third Quarter 2026 Results

Five Point Holdings, LLC (FPH) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Five Point Holdings, LLC Reports Third Quarter 2026 Results Third Quarter 2026 Highlights • Great Park Venture distributions and incentive compensation payments to the Company totaled $40.4 million. • Great Park builder sales of 54 homes during the quarter. • Valenci

SEC EDGAR 8-K2 min
SEP 16
$RMDMed

CSL, Resmed, and more. See which ASX health stocks RBC Capital Markets has upgraded

RBC Capital Markets upgraded five ASX-listed healthcare stocks to outperform, citing positive earnings growth and attractive valuations. CSL (ASX: CSL) was highlighted for market share gains, with a $213 price target. ResMed (ASX: RMD) was noted for capital management, with a $262 target. Ramsay Healthcare (ASX: RHC) was praised for cost control, with a $68 target. Fisher & Paykel (ASX: FPH) showed strong growth, with a $52 target. Nanosonics (ASX: NAN) had mixed results but a $3.75 target.

fool.com.au2 min
AUG 21
$FPHMedAI 8/10

Market quiet but earnings showing positive signs

Fisher & Paykel Healthcare upgraded its 2027 guidance, citing strong hospital product sales. Revenue and net profit forecasts increased, with first-half revenue expected at $1.24B and net profit at $280M. The stock closed at $43.52. On Wall Street, the Dow fell 1.32% as bond yields rose and Walmart missed earnings. In NZ, several companies reported earnings, including South Port NZ and Seeka.

nzherald.co.nz2 min
AUG 17
$FPHMed

FPH turns down KKR bid for First Gen stake over valuation

First Philippine Holdings (FPH) rejected KKR’s non-binding bid to buy an additional 8.43% stake in First Gen and then tender for First Gen’s public float at P36/share, saying it undervalues First Gen. FPH owns 67.84% of First Gen; KKR has 19.9% economic interest. The deal would have supported a delisting. First Gen also weighs a $5B offer from BREN for EDC.

bworldonline.com5 min